Extracting meaningful multi-omic insights from DNA and RNA sequencing data generated from challenging clinical specimens remains a common obstacle in biomarker-driven research and clinical trials. In this webinar, the featured speakers will discuss how nucleic acid yield and quality influence NGS success, review practical considerations when working with challenging clinical specimens and explain why FFPE remains one of the most important and challenging sample types for integrated genomic and transcriptomic analysis.
Through real-world examples, attendees will gain insights into approaches to maximize data generation, improve assay success rates and support confident decision-making in precision medicine programs.
Register for this webinar to learn how NGS Data quality can be maximised across challenging clinical samples, including FFPE specimens.
Who Should Attend
This webinar is intended for biopharma and biotech professionals involved in Translational Medicine, Clinical Development and biomarker-driven clinical trials. It will be particularly relevant to Scientists, Biomarker Leads, Data Scientists and biomarker programme decision-makers looking to maximize data generation from challenging clinical specimens to support precision medicine drug development.
This webinar will be of interest to:
Scientist / Principal Scientist / Senior Scientist
Translational Development Heads
Clinical Development Heads
Biomarker Leads
Data Scientists
What You Will Learn
Attendees will gain insight into:
How sample quality affects NGS Data generation and assay success
Practical considerations when working with challenging clinical specimens
Why FFPE remains one of the most important and most challenging sample types for NGS
Approaches to maximize data generation from challenging clinical specimens
Register free on Xtalks:
https://xtalks.com/webinars/unlocking-high-quality-ngs-data-from-challenging-clinical-samples/
